Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.
$162.55+0.38%
报价 2026-11-06
市值
$307B
EV
$307.86B
PE (TTM)
20.2x
预期 PE
–
52 周区间距高点 -3.6%
$124.36$168.62
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - General| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NVSNovartis AG | $307B | +0.4% | – | 76% | 20.2x | 13.5x | – | |
| JNJJohnson & Johnson | $664.95B | +1.4% | +7.6% | 73% | 21.3x | 14.9x | 34.0x | |
| ABBVAbbVie Inc. | $514.78B | +1.1% | +10.4% | 73.3% | 86.3x | 15.1x | 27.7x | GARP |
| MRKMerck & Co., Inc. | $361.96B | -0.2% | +3.6% | 73.5% | 121.5x | 30.7x | 23.5x | |
| AZNAstraZeneca PLC | $289.13B | -0.2% | – | 78.2% | 27.5x | 15.4x | – | |
| AMGNAmgen Inc. | $248.92B | +0.0% | +4.0% | 70.5% | 24.4x | 12.5x | 30.7x | |
| GILDGilead Sciences, Inc. | $207B | -0.4% | +4.1% | 81.1% | 20.0x | 14.5x | 21.9x | |
| NVONovo Nordisk A/S | $177.74B | +0.0% | – | 78.2% | 10.3x | 7.2x | – | Cheap |
| PFEPfizer Inc. | $167.51B | -0.2% | +1.4% | 72.8% | 37.3x | 17.7x | 14.7x | |
| 同行中位数 | – | – | +4.0% | 73.4% | 26.0x | 15.0x | 25.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-29 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.03B | $14.42B | $13.52B | $13.33B | $14.36B | $14.84B | $13.62B | $13.56B |
| Gross Margin | 76% | 74.5% | 74.4% | 73.4% | 75.4% | 77.6% | 76.3% | 75.5% |
| Operating Margin | 12.3% | 32.8% | 31.3% | 26.4% | 31.3% | 32.8% | 34.2% | 26% |
| Net Income | $1.2B | $3.27B | $3.16B | $2.41B | $3.93B | $4.04B | $3.61B | $2.82B |
| Diluted EPS | 0.63 | 1.71 | 1.65 | 1.25 | 2.02 | 2.06 | 1.82 | 1.41 |
| Operating Cash Flow | $5.5B | $5.89B | $3.68B | $2.25B | $6.57B | $6.66B | $3.65B | $4.19B |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。